Penumbra Net Income
| PEN Stock | USD 342.01 2.09 0.61% |
As of the 6th of February, Penumbra holds the Risk Adjusted Performance of 0.1665, coefficient of variation of 473.05, and Semi Deviation of 1.17. Compared to fundamental indicators, the technical analysis model allows you to check existing technical drivers of Penumbra, as well as the relationship between them.
Penumbra Total Revenue |
|
Gross Profit | Profit Margin | Market Capitalization | Enterprise Value Revenue 10.3099 | Revenue |
| Last Reported | Projected for Next Year | ||
| Net Income | 16.1 M | 15.4 M | |
| Net Income Applicable To Common Shares | 16.1 M | 16 M | |
| Net Income From Continuing Ops | 16.1 M | 16 M | |
| Net Income Per Share | 0.33 | 0.31 | |
| Net Income Per E B T | 0.60 | 0.63 |
Penumbra | Net Income | Build AI portfolio with Penumbra Stock |
Evaluating Penumbra's Net Income across multiple reporting periods reveals the company's ability to sustain growth and manage resources effectively. This longitudinal analysis highlights inflection points, cyclical patterns, and structural changes that short-term snapshots might miss, offering deeper insight into Penumbra's fundamental strength.
Latest Penumbra's Net Income Growth Pattern
Below is the plot of the Net Income of Penumbra over the last few years. Net income is one of the most important fundamental items in finance. It plays a large role in Penumbra financial statement analysis. It represents the amount of money remaining after all of Penumbra operating expenses, interest, taxes and preferred stock dividends have been deducted from a company total revenue. It is Penumbra's Net Income historical data analysis aims to capture in quantitative terms the overall pattern of either growth or decline in Penumbra's overall financial position and show how it may be relating to other accounts over time.
| View | Last Reported 14.01 M | 10 Years Trend |
|
Net Income |
| Timeline |
Penumbra Net Income Regression Statistics
| Arithmetic Mean | 12,121,801 | |
| Geometric Mean | 6,693,468 | |
| Coefficient Of Variation | 200.96 | |
| Mean Deviation | 14,839,390 | |
| Median | 4,099,000 | |
| Standard Deviation | 24,360,412 | |
| Sample Variance | 593.4T | |
| Range | 110.2M | |
| R-Value | 0.34 | |
| Mean Square Error | 560.6T | |
| R-Squared | 0.11 | |
| Significance | 0.18 | |
| Slope | 1,631,326 | |
| Total Sum of Squares | 9494.9T |
Penumbra Net Income History
Other Fundumenentals of Penumbra
| Net Income Applicable To Common Shares | ||
| Net Income From Continuing Ops | ||
| Net Income Per Share | ||
| Net Income Per E B T |
Penumbra Net Income component correlations
Penumbra Net Income Driver Correlations
Understanding the fundamental principles of building solid financial models for Penumbra is extremely important. It helps to project a fair market value of Penumbra Stock properly, considering its historical fundamentals such as Net Income. Since Penumbra's main accounts across its financial reports are all linked and dependent on each other, it is essential to analyze all possible correlations between related accounts. However, instead of reviewing all of Penumbra's historical financial statements, investors can examine the correlated drivers to determine its overall health. This can be effectively done using a conventional correlation matrix of Penumbra's interrelated accounts and indicators.
Click cells to compare fundamentals
Will Health Care Equipment & Supplies sector continue expanding? Could Penumbra diversify its offerings? Factors like these will boost the valuation of Penumbra. Anticipated expansion of Penumbra directly elevates investor willingness to pay premium valuations. Accurate valuation requires analyzing both current fundamentals and future growth trajectories. Every Penumbra data point contributes insight, yet successful analysis hinges on identifying the most consequential variables.
Quarterly Earnings Growth 0.56 | Earnings Share 4.01 | Revenue Per Share | Quarterly Revenue Growth 0.178 | Return On Assets |
Investors evaluate Penumbra using market value (trading price) and book value (balance sheet equity), each telling a different story. Calculating Penumbra's intrinsic value - the estimated true worth - helps identify when the stock trades at a discount or premium to fair value. Seasoned market participants apply comprehensive analytical frameworks to derive fundamental worth and identify mispriced opportunities. External factors like market trends, sector rotation, and investor psychology can cause Penumbra's market price to deviate significantly from intrinsic value.
It's important to distinguish between Penumbra's intrinsic value and market price, which are calculated using different methodologies. Investment decisions regarding Penumbra should consider multiple factors including financial performance, growth metrics, competitive position, and professional analysis. Conversely, Penumbra's market price signifies the transaction level at which participants voluntarily complete trades.
Penumbra 'What if' Analysis
In the world of financial modeling, what-if analysis is part of sensitivity analysis performed to test how changes in assumptions impact individual outputs in a model. When applied to Penumbra's stock what-if analysis refers to the analyzing how the change in your past investing horizon will affect the profitability against the current market value of Penumbra.
| 11/08/2025 |
| 02/06/2026 |
If you would invest 0.00 in Penumbra on November 8, 2025 and sell it all today you would earn a total of 0.00 from holding Penumbra or generate 0.0% return on investment in Penumbra over 90 days. Penumbra is related to or competes with Globus Medical, Bio Rad, Align Technology, HealthEquity, Hims Hers, DaVita HealthCare, and Charles River. Penumbra, Inc. designs, develops, manufactures, and markets medical devices in the United States and internationally More
Penumbra Upside/Downside Indicators
Understanding different market momentum indicators often help investors to time their next move. Potential upside and downside technical ratios enable traders to measure Penumbra's stock current market value against overall market sentiment and can be a good tool during both bulling and bearish trends. Here we outline some of the essential indicators to assess Penumbra upside and downside potential and time the market with a certain degree of confidence.
| Downside Deviation | 1.77 | |||
| Information Ratio | 0.1971 | |||
| Maximum Drawdown | 23.11 | |||
| Value At Risk | (2.61) | |||
| Potential Upside | 4.14 |
Penumbra Market Risk Indicators
Today, many novice investors tend to focus exclusively on investment returns with little concern for Penumbra's investment risk. Other traders do consider volatility but use just one or two very conventional indicators such as Penumbra's standard deviation. In reality, there are many statistical measures that can use Penumbra historical prices to predict the future Penumbra's volatility.| Risk Adjusted Performance | 0.1665 | |||
| Jensen Alpha | 0.6432 | |||
| Total Risk Alpha | 0.5095 | |||
| Sortino Ratio | 0.3507 | |||
| Treynor Ratio | 1.71 |
Sophisticated investors, who have witnessed many market ups and downs, anticipate that the market will even out over time. This tendency of Penumbra's price to converge to an average value over time is called mean reversion. However, historically, high market prices usually discourage investors that believe in mean reversion to invest, while low prices are viewed as an opportunity to buy.
Penumbra February 6, 2026 Technical Indicators
| Cycle Indicators | ||
| Math Operators | ||
| Math Transform | ||
| Momentum Indicators | ||
| Overlap Studies | ||
| Pattern Recognition | ||
| Price Transform | ||
| Statistic Functions | ||
| Volatility Indicators | ||
| Volume Indicators |
| Risk Adjusted Performance | 0.1665 | |||
| Market Risk Adjusted Performance | 1.72 | |||
| Mean Deviation | 1.84 | |||
| Semi Deviation | 1.17 | |||
| Downside Deviation | 1.77 | |||
| Coefficient Of Variation | 473.05 | |||
| Standard Deviation | 3.15 | |||
| Variance | 9.94 | |||
| Information Ratio | 0.1971 | |||
| Jensen Alpha | 0.6432 | |||
| Total Risk Alpha | 0.5095 | |||
| Sortino Ratio | 0.3507 | |||
| Treynor Ratio | 1.71 | |||
| Maximum Drawdown | 23.11 | |||
| Value At Risk | (2.61) | |||
| Potential Upside | 4.14 | |||
| Downside Variance | 3.14 | |||
| Semi Variance | 1.37 | |||
| Expected Short fall | (2.30) | |||
| Skewness | 2.86 | |||
| Kurtosis | 13.36 |
Penumbra Backtested Returns
Penumbra appears to be very steady, given 3 months investment horizon. Penumbra maintains Sharpe Ratio (i.e., Efficiency) of 0.18, which implies the firm had a 0.18 % return per unit of risk over the last 3 months. We have found twenty-eight technical indicators for Penumbra, which you can use to evaluate the volatility of the company. Please evaluate Penumbra's Coefficient Of Variation of 473.05, risk adjusted performance of 0.1665, and Semi Deviation of 1.17 to confirm if our risk estimates are consistent with your expectations. On a scale of 0 to 100, Penumbra holds a performance score of 14. The company holds a Beta of 0.38, which implies possible diversification benefits within a given portfolio. As returns on the market increase, Penumbra's returns are expected to increase less than the market. However, during the bear market, the loss of holding Penumbra is expected to be smaller as well. Please check Penumbra's maximum drawdown, as well as the relationship between the expected short fall and rate of daily change , to make a quick decision on whether Penumbra's historical price patterns will revert.
Auto-correlation | 0.65 |
Good predictability
Penumbra has good predictability. Overlapping area represents the amount of predictability between Penumbra time series from 8th of November 2025 to 23rd of December 2025 and 23rd of December 2025 to 6th of February 2026. The more autocorrelation exist between current time interval and its lagged values, the more accurately you can make projection about the future pattern of Penumbra price movement. The serial correlation of 0.65 indicates that roughly 65.0% of current Penumbra price fluctuation can be explain by its past prices.
| Correlation Coefficient | 0.65 | |
| Spearman Rank Test | 0.65 | |
| Residual Average | 0.0 | |
| Price Variance | 431.02 |
Because income is reported on the Income Statement of a company and is measured in dollars some investors prefer to use Profit Margin, which measures income as a percentage of sales.
| Competition |
Penumbra Accumulated Other Comprehensive Income
Accumulated Other Comprehensive Income |
|
Based on the recorded statements, Penumbra reported net income of 14.01 M. This is 95.89% lower than that of the Health Care Equipment & Supplies sector and 94.12% lower than that of the Health Care industry. The net income for all United States stocks is 97.55% higher than that of the company.
Penumbra Net Income Peer Comparison
Stock peer comparison is one of the most widely used and accepted methods of equity analyses. It analyses Penumbra's direct or indirect competition against its Net Income to detect undervalued stocks with similar characteristics or determine the stocks which would be a good addition to a portfolio. Peer analysis of Penumbra could also be used in its relative valuation, which is a method of valuing Penumbra by comparing valuation metrics of similar companies.Penumbra is currently under evaluation in net income category among its peers.
Penumbra ESG Sustainability
Some studies have found that companies with high sustainability scores are getting higher valuations than competitors with lower social-engagement activities. While most ESG disclosures are voluntary and do not directly affect the long term financial condition, Penumbra's sustainability indicators can be used to identify proper investment strategies using environmental, social, and governance scores that are crucial to Penumbra's managers, analysts, and investors.Environmental | Governance | Social |
Penumbra Institutional Holders
Institutional Holdings refers to the ownership stake in Penumbra that is held by large financial organizations, pension funds or endowments. Institutions may hold large blocks of Penumbra's outstanding shares and can exert considerable influence upon its management. Institutional holders may also work to push the share price higher once they own the stock. Extensive social media coverage, TV shows, articles in high-profile magazines, and presentations at investor conferences help move the stock higher, increasing Penumbra's value.| Shares | Amvescap Plc. | 2025-06-30 | 633.5 K | Capital World Investors | 2025-06-30 | 545.2 K | Hhg Plc | 2025-06-30 | 531.2 K | Morgan Stanley - Brokerage Accounts | 2025-06-30 | 498.6 K | Congress Asset Management Company, Llp | 2025-06-30 | 454.7 K | Norges Bank | 2025-06-30 | 444.3 K | Aqr Capital Management Llc | 2025-06-30 | 331 K | Thrivent Financial For Lutherans | 2025-06-30 | 322.9 K | Allspring Global Investments Holdings, Llc | 2025-06-30 | 322 K | Fmr Inc | 2025-06-30 | 5.9 M | Blackrock Inc | 2025-06-30 | 4.2 M |
Penumbra Fundamentals
| Return On Equity | 0.13 | ||||
| Return On Asset | 0.067 | ||||
| Profit Margin | 0.12 % | ||||
| Operating Margin | 0.14 % | ||||
| Current Valuation | 13.75 B | ||||
| Shares Outstanding | 39.23 M | ||||
| Shares Owned By Insiders | 3.72 % | ||||
| Shares Owned By Institutions | 97.89 % | ||||
| Number Of Shares Shorted | 1.72 M | ||||
| Price To Earning | 191.13 X | ||||
| Price To Book | 10.31 X | ||||
| Price To Sales | 10.00 X | ||||
| Revenue | 1.19 B | ||||
| Gross Profit | 890.99 M | ||||
| EBITDA | 45.99 M | ||||
| Net Income | 14.01 M | ||||
| Cash And Equivalents | 324.4 M | ||||
| Cash Per Share | 5.39 X | ||||
| Total Debt | 223.39 M | ||||
| Debt To Equity | 0.23 % | ||||
| Current Ratio | 4.93 X | ||||
| Book Value Per Share | 34.70 X | ||||
| Cash Flow From Operations | 168.48 M | ||||
| Short Ratio | 1.81 X | ||||
| Earnings Per Share | 4.01 X | ||||
| Price To Earnings To Growth | 0.82 X | ||||
| Target Price | 348.53 | ||||
| Number Of Employees | 4.5 K | ||||
| Beta | 0.81 | ||||
| Market Capitalization | 13.33 B | ||||
| Total Asset | 1.53 B | ||||
| Retained Earnings | 60 M | ||||
| Working Capital | 792.78 M | ||||
| Current Asset | 244.36 M | ||||
| Current Liabilities | 28.15 M | ||||
| Net Asset | 1.53 B |
About Penumbra Fundamental Analysis
The Macroaxis Fundamental Analysis modules help investors analyze Penumbra's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of Penumbra using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of Penumbra based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Please read more on our fundamental analysis page.
Pair Trading with Penumbra
One of the main advantages of trading using pair correlations is that every trade hedges away some risk. Because there are two separate transactions required, even if Penumbra position performs unexpectedly, the other equity can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Penumbra will appreciate offsetting losses from the drop in the long position's value.Moving against Penumbra Stock
| 0.84 | OTC | Ocumetics Technology Corp | PairCorr |
| 0.84 | AHC | Austco Healthcare | PairCorr |
| 0.74 | IHC | Inspiration Healthcare | PairCorr |
| 0.7 | IVF | INVO Fertility Symbol Change | PairCorr |
| 0.65 | RHT | Resonance Health | PairCorr |
The ability to find closely correlated positions to Penumbra could be a great tool in your tax-loss harvesting strategies, allowing investors a quick way to find a similar-enough asset to replace Penumbra when you sell it. If you don't do this, your portfolio allocation will be skewed against your target asset allocation. So, investors can't just sell and buy back Penumbra - that would be a violation of the tax code under the "wash sale" rule, and this is why you need to find a similar enough asset and use the proceeds from selling Penumbra to buy it.
The correlation of Penumbra is a statistical measure of how it moves in relation to other instruments. This measure is expressed in what is known as the correlation coefficient, which ranges between -1 and +1. A perfect positive correlation (i.e., a correlation coefficient of +1) implies that as Penumbra moves, either up or down, the other security will move in the same direction. Alternatively, perfect negative correlation means that if Penumbra moves in either direction, the perfectly negatively correlated security will move in the opposite direction. If the correlation is 0, the equities are not correlated; they are entirely random. A correlation greater than 0.8 is generally described as strong, whereas a correlation less than 0.5 is generally considered weak.
Correlation analysis and pair trading evaluation for Penumbra can also be used as hedging techniques within a particular sector or industry or even over random equities to generate a better risk-adjusted return on your portfolios.Check out To learn how to invest in Penumbra Stock, please use our How to Invest in Penumbra guide.You can also try the Economic Indicators module to top statistical indicators that provide insights into how an economy is performing.
Will Health Care Equipment & Supplies sector continue expanding? Could Penumbra diversify its offerings? Factors like these will boost the valuation of Penumbra. Anticipated expansion of Penumbra directly elevates investor willingness to pay premium valuations. Accurate valuation requires analyzing both current fundamentals and future growth trajectories. Every Penumbra data point contributes insight, yet successful analysis hinges on identifying the most consequential variables.
Quarterly Earnings Growth 0.56 | Earnings Share 4.01 | Revenue Per Share | Quarterly Revenue Growth 0.178 | Return On Assets |
Investors evaluate Penumbra using market value (trading price) and book value (balance sheet equity), each telling a different story. Calculating Penumbra's intrinsic value - the estimated true worth - helps identify when the stock trades at a discount or premium to fair value. Seasoned market participants apply comprehensive analytical frameworks to derive fundamental worth and identify mispriced opportunities. External factors like market trends, sector rotation, and investor psychology can cause Penumbra's market price to deviate significantly from intrinsic value.
It's important to distinguish between Penumbra's intrinsic value and market price, which are calculated using different methodologies. Investment decisions regarding Penumbra should consider multiple factors including financial performance, growth metrics, competitive position, and professional analysis. Conversely, Penumbra's market price signifies the transaction level at which participants voluntarily complete trades.